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• Congress Abstract 
Verbascoside (acteoside) is a phenylpropanoid glycoside widely spread in nature. Different biological 
activities have been reported for such compound: anti-inflammatory, anti-ulcerogenic and 
antispasmodic activity [1], antiproliferative properties and inhibition of telomerase [2], 
immunomodulatory [3], antioxidant and photoprotective [4] and analgesic activities [5]. This study 
reports on the rapid isolation of verbascoside fromLippia citriodora H.B.K. (Verbenaceae), a not 
expensive and widespread source and its antihyperalgesic activity. Size exclusion chromatography with 
Sephadex LH-20, using hydroalcoholic solution (50% EtOH) is proposed as a fast and efficient method 
for the isolation and purification of verbascoside (purity &gt;98% determined by HPLC/DAD/ESI MS). 
The antihyperalgesic activity of verbascoside was tested by in vivo assay, using the Paw-pressure test, 
in two animal models of neuropathic pain: a peripheral mononeuropathy produced either by a chronic 
constriction injury of the sciatic nerve (CCI), or by an intra-articular injection of sodium 
monoiodoacetate (MIA). Verbascoside administered intraperitoneally (i.p.) at the dose of 100mg/kg, 
reverted the mechanical hyperalgesia in both CCI and MIA treated rats, evaluated in the Paw-pressure 
test. The antihyperalgesic effect started 15min. after administration and persisted for 30-45min. 
Verbascoside was also effective against mechanical hyperalgesia after oral administration. At the doses 
of 300 and 600mg/kg p.o. reverted the hyperalgesia induced by both CCI and MIA injection: the 
antihyperalgesic effect started 15min after administration and was still significant at 60min. 
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